Nephron最新文献

筛选
英文 中文
Self-Reported Fatigue by the Chalder Fatigue Questionnaire and Mortality in Brazilian Hemodialysis Patients: The PROHEMO. 巴西血液透析患者自我报告疲劳的Chalder疲劳问卷和死亡率:PROHEMO。
IF 2.5 4区 医学
Nephron Pub Date : 2024-01-01 Epub Date: 2023-12-02 DOI: 10.1159/000533472
Gabriel Brayan Gutiérrez-Peredo, Márcia Tereza Silva Martins, Fernanda Albuquerque da Silva, Marcelo Barreto Lopes, Gildete Barreto Lopes, Keith C Norris, Antonio Alberto Lopes
{"title":"Self-Reported Fatigue by the Chalder Fatigue Questionnaire and Mortality in Brazilian Hemodialysis Patients: The PROHEMO.","authors":"Gabriel Brayan Gutiérrez-Peredo, Márcia Tereza Silva Martins, Fernanda Albuquerque da Silva, Marcelo Barreto Lopes, Gildete Barreto Lopes, Keith C Norris, Antonio Alberto Lopes","doi":"10.1159/000533472","DOIUrl":"10.1159/000533472","url":null,"abstract":"<p><strong>Background: </strong>The existing data support the Chalder Fatigue Questionnaire (CFQ-11) as a valid instrument to assess fatigue in maintenance hemodialysis (MHD) patients. The objective of this work was to investigate whether self-reported fatigue can serve as an independent prognostic indicator for mortality in MHD patients.</p><p><strong>Methods: </strong>The data are from 233 adult patients enrolled in the cohort \"The Prospective Study of the Prognosis of Chronic Hemodialysis Patients\" (PROHEMO) developed in Salvador, BA, Brazil. The Brazilian version of the validated CFQ-11 was used to calculate self-reported fatigue. The CFQ-11 scores may range from 0 to 33; higher scores represent more fatigue. Fatigue categories were created based on proposed cut point: absence or mild degree if CFQ-11 scores &lt;4 and moderate to severe if scores ≥4. Cox models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) of associations between fatigue and mortality with adjustments for sociodemographic factors, time on dialysis, education, economic class, hemoglobin concentration, diabetes, heart failure, depression, and other psychiatric disorders.</p><p><strong>Results: </strong>The mean age was 51.5 ± 2.5 years, 58% were male, and 30% were diabetic. Self-reported moderate to severe fatigue was reported by 71% of patients. The mortality rate was 8.6 cases/100 person-years. Patients with moderate to severe fatigue had a more than threefold mortality rate (HR = 3.07, 95% CI: 1.19, 7.93) compared to patients with absent or mild fatigue, after extensive adjustments for covariates.</p><p><strong>Conclusion: </strong>The study provides evidence that self-reported fatigue can help identify MHD patients at higher risk of earlier death.</p>","PeriodicalId":18998,"journal":{"name":"Nephron","volume":" ","pages":"292-299"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138478206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urine Uromodulin, Kidney Tubulointerstitial Fibrosis, and Furosemide Response. 尿调素、肾小管间质纤维化和速尿反应。
IF 2.3 4区 医学
Nephron Pub Date : 2024-01-01 Epub Date: 2023-12-01 DOI: 10.1159/000534578
Alexander L Bullen, Sucheta Vaingankar, Magdalena Madero, Salvador Lopez Gil, Etienne Macedo, Joachim H Ix, Dena E Rifkin, Pranav S Garimella
{"title":"Urine Uromodulin, Kidney Tubulointerstitial Fibrosis, and Furosemide Response.","authors":"Alexander L Bullen, Sucheta Vaingankar, Magdalena Madero, Salvador Lopez Gil, Etienne Macedo, Joachim H Ix, Dena E Rifkin, Pranav S Garimella","doi":"10.1159/000534578","DOIUrl":"10.1159/000534578","url":null,"abstract":"<p><strong>Background: </strong>Interstitial fibrosis and tubular atrophy (IFTA) are common findings on biopsy in chronic kidney disease (CKD) and are strongly predictive of kidney failure. IFTA is poorly correlated with estimated glomerular filtration rate (eGFR) and albuminuria, the most common measures of kidney function. Thus, IFTA is prognostically important, yet its presence and severity are invisible to the clinician except when kidney biopsies are obtained.</p><p><strong>Objectives: </strong>The objective of this study was to investigate (1) the cross-sectional association between urine uromodulin (uUMOD) and IFTA and (2) to determine whether uUMOD levels were associated with diuretic response after a furosemide stress test.</p><p><strong>Methods: </strong>We performed logistic regression to evaluate the association between uUMOD and fibrosis. We used linear regression models to assess the association of uUMOD with diuretic response.</p><p><strong>Results: </strong>Among 52 participants, the mean age was 42 ± 16 years, 48% were women, 23% had diabetes, and the median eGFR was 56 mL/min/1.73 m2. The mean uUMOD concentration was 5.1 (8.4) μg/mL. Each halving of uUMOD was associated with 1.74 higher odds (95% CI: 1.10, 2.75) of grade 2 or 3 fibrosis. However, this association was no longer significant after adjusting for baseline eGFR and albuminuria. Each halving of uUMOD was associated with a decreased response to furosemide. This association was also no longer significant after adjusting for baseline eGFR and albuminuria.</p><p><strong>Conclusion: </strong>In a population of individuals with a wide range of kidney function undergoing clinically indicated kidney biopsies, we did not find an association between uUMOD and interstitial fibrosis or response to loop diuretics after adjusting for eGFR and albuminuria.</p>","PeriodicalId":18998,"journal":{"name":"Nephron","volume":" ","pages":"443-447"},"PeriodicalIF":2.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11216347/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138478207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Arteriolar Hyalinosis Predicts the Onset of Both Macroalbuminuria and Impaired Renal Function in Patients with Type 2 Diabetes. 动脉毛细血管钙化可预测 2 型糖尿病患者开始出现巨蛋白尿和肾功能受损。
IF 2.3 4区 医学
Nephron Pub Date : 2024-01-01 Epub Date: 2023-12-20 DOI: 10.1159/000535875
Akihiko Suzuki, Tatsumi Moriya, Akinori Hayashi, Madoka Matsubara, Takeshi Miyatsuka
{"title":"Arteriolar Hyalinosis Predicts the Onset of Both Macroalbuminuria and Impaired Renal Function in Patients with Type 2 Diabetes.","authors":"Akihiko Suzuki, Tatsumi Moriya, Akinori Hayashi, Madoka Matsubara, Takeshi Miyatsuka","doi":"10.1159/000535875","DOIUrl":"10.1159/000535875","url":null,"abstract":"<p><strong>Introduction: </strong>Arteriolar hyalinosis (AH) has been shown to be associated with albuminuria and GFR. In this study, we investigated whether or not index of AH (IAH) is a predictor of the onset of macroalbuminuria and impaired renal function (eGFR &lt;60 mL/min/1.73 m2 [eGFR &lt;60]) in type 2 diabetic patients with early diabetic nephropathy.</p><p><strong>Methods: </strong>The study population consisted of 35 patients with type 2 diabetes (25 men; age: 47 ± 9 years; eGFR: 92.7 ± 18.0 mL/min/1.73 m2) with normo- or microalbuminuria who underwent percutaneous renal biopsy. These patients were followed for at least 5 (18 ± 6, range: 6-28) years. The study endpoint was the onset of macroalbuminuria or eGFR &lt;60. Light and electron microscopy-based morphometric analyses were performed to quantitatively evaluate glomerular and interstitial structural changes.</p><p><strong>Results: </strong>During the observation period, 9 out of the 35 patients progressed to macroalbuminuria, and 15 out of the 35 patients developed eGFR &lt;60. The annual rate of eGFR decline was significantly correlated with IAH (r = -0.40, p = 0.016). Kaplan-Meier analysis demonstrated that AH was associated with a significantly higher risk of onset of macroalbuminuria and eGFR &lt;60, and microalbuminuria is associated with the onset of macroalbuminuria but not the onset of eGFR &lt;60.</p><p><strong>Conclusions: </strong>Aggravated AH is a histological risk factor which predicts the onset of macroalbuminuria and eGFR &lt;60 in patients with type 2 diabetes. These findings provide novel insights into the mechanism of progression of diabetic nephropathy.</p>","PeriodicalId":18998,"journal":{"name":"Nephron","volume":" ","pages":"390-398"},"PeriodicalIF":2.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11151987/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138830667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous Erythropoietin Receptor Activator for the Treatment of Chronic Dialysis Patients with Renal Anemia in Daily Clinical Practice in Poland: A Non-Interventional, Multi-Center, Pragmatic NAVIGO Trial. 连续性促红细胞生成素受体激活剂用于治疗波兰日常临床实践中患有肾性贫血的慢性透析患者:一项非干预、多中心、务实的 NAVIGO 试验。
IF 2.5 4区 医学
Nephron Pub Date : 2024-01-01 Epub Date: 2023-09-14 DOI: 10.1159/000534070
Michał Nowicki, Maciej Drożdż, Jarosław Wajda, Wiesław Klatko, Agnieszka Segiet-Święcicka
{"title":"Continuous Erythropoietin Receptor Activator for the Treatment of Chronic Dialysis Patients with Renal Anemia in Daily Clinical Practice in Poland: A Non-Interventional, Multi-Center, Pragmatic NAVIGO Trial.","authors":"Michał Nowicki, Maciej Drożdż, Jarosław Wajda, Wiesław Klatko, Agnieszka Segiet-Święcicka","doi":"10.1159/000534070","DOIUrl":"10.1159/000534070","url":null,"abstract":"<p><strong>Background: </strong>Renal anemia is one of the most common complications of chronic kidney disease (CKD). This real-life study assessed the effectiveness of methoxy polyethylene glycol-epoetin beta, a continuous erythropoietin receptor activator (C.E.R.A.), for the treatment of CKD-associated anemia in patients receiving dialysis in daily clinical practice.</p><p><strong>Methods: </strong>247 patients receiving chronic intermitted dialysis in 26 centers in Poland with CKD-associated symptomatic anemia, ESA-naïve, and with balanced iron stores in the investigators' opinion were enrolled this real-life study. Over 12 months, the following data were collected: hemoglobin (Hb) concentration and dosage, route of administration and dosing scheme of C.E.R.A., dialysis adequacy, adverse events, iron therapy, and blood transfusions.</p><p><strong>Results: </strong>During the treatment, a Hb concentration of ≥10 g/dL was noted in 90.9% of hemodialysis patients (n = 224) and 96.0% of peritoneal dialysis patients (n = 23). At baseline, 7.8% of patients had a Hb concentration of 10-12 g/dL, which increased to 63.3% after 12 months. The median time when Hb concentration was maintained within 10-12 g/dL was 115.2 (interquartile range 49.1-188.7) days. A Hb concentration ≥12 g/dL was observed after 7 months of treatment in a maximum of 24.1% of hemodialysis patients, and 31.8% of peritoneal dialysis patients. The median time elapsed between the start of treatment and the first Hb concentration &gt;10 g/dL was 42.0 (21.0-78.2) days. C.E.R.A. was well tolerated.</p><p><strong>Conclusions: </strong>C.E.R.A. corrects CKD-associated anemia in dialysis patients, and maintains Hb levels within the recommended target range. The study also confirmed the acceptable safety profile of the drug.</p>","PeriodicalId":18998,"journal":{"name":"Nephron","volume":" ","pages":"104-112"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10860886/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10233676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the European Kidney Function Consortium Equation in Chinese Adult Population: An Equation Standing on the Shoulders of Predecessors. 欧洲肾功能联合会公式在中国成年人群中的验证:站在前人肩膀上的方程。
IF 2.5 4区 医学
Nephron Pub Date : 2024-01-01 Epub Date: 2023-06-14 DOI: 10.1159/000531030
Yao Ma, Lu Wei, Zhenzhu Yong, Yue Yu, Yi Chen, Bei Zhu, Weihong Zhao
{"title":"Validation of the European Kidney Function Consortium Equation in Chinese Adult Population: An Equation Standing on the Shoulders of Predecessors.","authors":"Yao Ma, Lu Wei, Zhenzhu Yong, Yue Yu, Yi Chen, Bei Zhu, Weihong Zhao","doi":"10.1159/000531030","DOIUrl":"10.1159/000531030","url":null,"abstract":"<p><strong>Background: </strong>Equations based on serum creatinine (SCr) have been extensively applied to estimate glomerular filtration rate (GFR), but their performance is debatable. In 2021, the European Kidney Function Consortium (EKFC) published one novel SCr-based formula, which combined the feature of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and full age spectrum (FAS) equations, but its potential applications remain unknown. We seek to assess the appropriateness of the three equations in Chinese adults.</p><p><strong>Methods: </strong>A total of 3,692 participants (median age, 54 years) were included. Reference GFR (rGFR) was measured by the 99mTc-DTPA renal dynamic imaging method. Estimated GFR (eGFR) was calculated by the CKD-EPI, FAS, and EKFC equations. Correlation coefficients and Bland-Altman analysis were adopted to evaluate their validity. The performance was assessed in subgroups according to age, sex, rGFR, and SCr, considering the bias, accuracy, and precision.</p><p><strong>Results: </strong>The average rGFR was 74.2 mL/min/1.73 m2. eGFR by EKFC showed a relatively stronger correlation with rGFR (R = 0.749) and a larger area under the receiver operating characteristic curve (0.902). EKFC was significantly less biased and exhibited the highest P30 in the entire population (bias = 3.61, P30 = 73.3%). It also performed well in all analyzed subgroups, especially in participants with normal or slightly impaired renal function (rGFR≥60 mL/min/1.73 m2), and low SCr.</p><p><strong>Conclusions: </strong>Compared to the other two SCr-based formulas, EKFC performed better in the Chinese. Thus, it might serve as a good alternative, until a more suitable formula is developed for the Chinese population.</p>","PeriodicalId":18998,"journal":{"name":"Nephron","volume":" ","pages":"63-73"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9624087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concurrent Cobalamin C and Plasminogen Deficiencies in a Patient with Chronic Thrombotic Microangiopathy. 一名慢性血栓性微血管病患者同时缺乏钴胺素 C 和凝血酶原。
IF 2.5 4区 医学
Nephron Pub Date : 2024-01-01 Epub Date: 2023-08-23 DOI: 10.1159/000533417
Ahmet Burak Dirim, Seda Safak, Mehmet Cihan Balci, Pelin Ozyavuz, Nurane Garayeva, Tarik Onur Tiryaki, Ozgur Akin Oto, Yasemin Ozluk, Isin Kilicaslan, Seyhun Solakoglu, Ayse Serra Artan, Halil Yazici, Aydin Turkmen, Savas Ozturk
{"title":"Concurrent Cobalamin C and Plasminogen Deficiencies in a Patient with Chronic Thrombotic Microangiopathy.","authors":"Ahmet Burak Dirim, Seda Safak, Mehmet Cihan Balci, Pelin Ozyavuz, Nurane Garayeva, Tarik Onur Tiryaki, Ozgur Akin Oto, Yasemin Ozluk, Isin Kilicaslan, Seyhun Solakoglu, Ayse Serra Artan, Halil Yazici, Aydin Turkmen, Savas Ozturk","doi":"10.1159/000533417","DOIUrl":"10.1159/000533417","url":null,"abstract":"<p><strong>Background: </strong>Although most patients with atypical hemolytic uremic syndrome (aHUS) have variants in genes participating in alternative complement pathways, rare variants in non-complement pathway-related genes, including DGKE, INF2, MMACHC, PLG, and THBD, have also been described.</p><p><strong>Case presentation: </strong>We report an 18-year-old male patient with renal biopsy-proven chronic thrombotic microangiopathy that raised suspicion of aHUS. Whole-exome sequencing revealed a novel pathogenic homozygous MMACHC c.484G&gt;T (p.Gly162Trp) variant. Subsequently, clinical and laboratory findings confirmed cobalamin C (Cbl C) deficiency. Also, homozygous missense c.1112C&gt;T PLG (p.Thr371Ile) variant was detected (it had been reported as a variant of unknown significance). However, the low serum plasminogen (PLG) activity proved the pathogenicity of c.1112C&gt;T. Hence, the patient was diagnosed with concurrent Cbl C and PLG deficiencies. Segregation analysis revealed that the mother and father had the same heterozygous PLG and MMACHC variants. PLG variants have generally been described in aHUS patients concomitant with complement gene variants in the literature; therefore, the association between aHUS and PLG variants is controversial. The possible contribution of PLG deficiency to thrombotic microangiopathy was also discussed in this case.</p><p><strong>Conclusion: </strong>Non-complement-mediated aHUS is an exceptional disorder. A limited number of genes are involved in this entity. To our knowledge, this is the first aHUS patient diagnosed with both Cbl C and PLG deficiencies in the literature.</p>","PeriodicalId":18998,"journal":{"name":"Nephron","volume":" ","pages":"54-62"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10058545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic Kidney Disease Risk in Living Kidney Transplant Donors: A Long-Term Follow-Up Study. 活体肾移植捐献者患慢性肾脏疾病的风险:一项长期随访研究。
IF 2.5 4区 医学
Nephron Pub Date : 2024-01-01 Epub Date: 2023-10-03 DOI: 10.1159/000534397
Guldehan Haberal, Tolga Yildirim, Seref Rahmi Yilmaz, Bulent Altun, Fazil Tuncay Aki, Yunus Erdem, Mustafa Arici
{"title":"Chronic Kidney Disease Risk in Living Kidney Transplant Donors: A Long-Term Follow-Up Study.","authors":"Guldehan Haberal, Tolga Yildirim, Seref Rahmi Yilmaz, Bulent Altun, Fazil Tuncay Aki, Yunus Erdem, Mustafa Arici","doi":"10.1159/000534397","DOIUrl":"10.1159/000534397","url":null,"abstract":"<p><strong>Background: </strong>Living kidney donors (LKD) may experience some untoward consequences following donation such as development of chronic kidney disease (CKD). In this study, we aimed to investigate the rate of development of CKD and factors affecting the development of CKD in LKDs during long-term follow-up from a center in Turkey.</p><p><strong>Methods: </strong>This study was a retrospective analysis of LKDs followed between January 2000 and December 2017. Pre-transplant and post-transplant clinical data of the 338 LKDs were recorded and compared. Factors affecting the development of stage 3 and later stages of CKD were analyzed.</p><p><strong>Results: </strong>Majority of the donors were females (64.2%), and the median age of all donors was 47 (39-54) years. Stage 3 CKD developed in 50 donors during the median follow-up of 71 months. Older age at the time of transplantation and a low pre-transplant estimated glomerular filtration rate (eGFR) were determined as the factors affecting the development of stage 3 CKD (p &lt; 0.001, p &lt; 0.001). The receiver operating characteristic analysis showed that the cut-off age for the development of stage 3 CKD was 50.5 years. Newly diagnosed hypertension was detected in 57 patients (16.8%) after the transplantation. While hypertension was seen at a rate of 42% in those with an eGFR &lt;60 mL/min/1.73 m2, it was detected at 19.4% in the group with an eGFR &gt;60 mL/min/1.73 m2 (p &lt; 0.001).</p><p><strong>Conclusion: </strong>These results reveal that being a LKD is associated with the development of CKD and hypertension. Age and eGFR values at the time of transplantation were the determinants for the development of CKD.</p>","PeriodicalId":18998,"journal":{"name":"Nephron","volume":" ","pages":"171-178"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41157039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human Beta Cell Functional Adaptation and Dysfunction in Insulin Resistance and Its Reversibility. 人β细胞在胰岛素抵抗中的功能适应和功能障碍及其可逆性。
IF 2.5 4区 医学
Nephron Pub Date : 2024-01-01 Epub Date: 2023-10-26 DOI: 10.1159/000534667
Maša Skelin Klemen, Jan Kopecky, Jurij Dolenšek, Andraž Stožer
{"title":"Human Beta Cell Functional Adaptation and Dysfunction in Insulin Resistance and Its Reversibility.","authors":"Maša Skelin Klemen, Jan Kopecky, Jurij Dolenšek, Andraž Stožer","doi":"10.1159/000534667","DOIUrl":"10.1159/000534667","url":null,"abstract":"<p><strong>Background: </strong>Beta cells play a key role in the pathophysiology of diabetes since their functional adaptation is able to maintain euglycemia in the face of insulin resistance, and beta cell decompensation or dysfunction is a necessary condition for full-blown type 2 diabetes (T2D). The mechanisms behind compensation and decompensation are incompletely understood, especially for human beta cells, and even less is known about influences of chronic kidney disease (CKD) or immunosupressive therapy after transplantation on these processes and the development of posttransplant diabetes.</p><p><strong>Summary: </strong>During compensation, beta cell sensitivity to glucose becomes left-shifted, i.e., their sensitivity to stimulation increases, and this is accompanied by enhanced signals along the stimulus-secretion coupling cascade from membrane depolarization to intracellular calcium and the most distal insulin secretion dynamics. There is currently no clear evidence regarding changes in intercellular coupling during this stage of disease progression. During decompensation, intracellular stimulus-secretion coupling remains enhanced to some extent at low or basal glucose concentrations but seems to become unable to generate effective signals to stimulate insulin secretion at high or otherwise stimulatory glucose concentrations. Additionally, intercellular coupling becomes disrupted, lowering the number of cells that contribute to secretion. During progression of CKD, beta cells also seem to drift from a compensatory left-shift to failure, and immunosupressants can further impair beta cell function following kidney transplantation.</p><p><strong>Key messages: </strong>Beta cell stimulus-secretion coupling is enhanced in compensated insulin resistance. With worsening insulin resistance, both intra- and intercellular coupling become disrupted. CKD can progressively disrupt beta cell function, but further studies are needed, especially regarding changes in intercellular coupling.</p>","PeriodicalId":18998,"journal":{"name":"Nephron","volume":" ","pages":"78-84"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10860743/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54230199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kidney Supportive Care for Working-Age Adults with Chronic Kidney Disease: A Profile of Characteristics and Symptom Burden. 工作年龄成人慢性肾脏病患者的肾脏支持性护理:特征和症状负担概况。
IF 2.5 4区 医学
Nephron Pub Date : 2024-01-01 Epub Date: 2023-07-10 DOI: 10.1159/000531872
Jiayi Liu, Louise Purtell, Ann Bonner
{"title":"Kidney Supportive Care for Working-Age Adults with Chronic Kidney Disease: A Profile of Characteristics and Symptom Burden.","authors":"Jiayi Liu, Louise Purtell, Ann Bonner","doi":"10.1159/000531872","DOIUrl":"10.1159/000531872","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic kidney disease (CKD) affects people across their lifespan. Kidney supportive care (KSC) is typically offered for older people for symptom management, education, and/or advance care planning (ACP). However, younger people may also benefit from KSC. This study sought to explore characteristics of working-age adults with CKD accessing KSC.</p><p><strong>Methods: </strong>Using a cross-sectional design, working-age adults (18-64 years) with CKD referred to a KSC service from February 2016 to July 2021 were included. Demographic and clinical data were extracted from patients' hospital records. Self-reported symptoms (Integrated Palliative Care Outcome Scale renal [IPOS-renal]) and health-related quality of life (European quality of life [EQ-5D-5L]) were assessed. Reasons for referral to KSC, kidney replacement therapy (KRT) pathway at referral, and comorbidity calculated using the Charlson Comorbidity Index were also assessed.</p><p><strong>Results: </strong>One Hundred Fifty-six working-age adults attended the KSC service. Median age was 57 years, with more than half receiving KRT. Weakness (92.2%), poor mobility (83.3%), and pain (82.5%) were the most prevalent and severe symptoms. The majority were referred for symptom management (n = 83, 53.2%) and 27% for ACP (n = 42). The ACP completion rate was low (28.9%). Those on dialysis had significantly higher symptom scores than those not receiving dialysis (p &lt; 0.05).</p><p><strong>Conclusion: </strong>Working-age adults with CKD experience a significant and debilitating symptom burden and need to consider options for treatment. This study provides new understanding about working-age adults with CKD that may help provide the specific support needed to meet their end-of-life care needs.</p>","PeriodicalId":18998,"journal":{"name":"Nephron","volume":" ","pages":"34-42"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10125773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of CT-Guided Kidney Biopsy for the Diagnosis of Glomerular Diseases in Complicated Patients. CT引导下肾脏活组织检查诊断并发症患者肾小球疾病的有效性和安全性。
IF 2.5 4区 医学
Nephron Pub Date : 2024-01-01 Epub Date: 2023-07-10 DOI: 10.1159/000531378
Javier Vian, Amir Shabaka, Silvia Lallena, Serena Gatius, Virginia Lopez de la Manzanara, Jeronimo Barrera-Ortega, Ramiro J Méndez-Fernández
{"title":"Efficacy and Safety of CT-Guided Kidney Biopsy for the Diagnosis of Glomerular Diseases in Complicated Patients.","authors":"Javier Vian, Amir Shabaka, Silvia Lallena, Serena Gatius, Virginia Lopez de la Manzanara, Jeronimo Barrera-Ortega, Ramiro J Méndez-Fernández","doi":"10.1159/000531378","DOIUrl":"10.1159/000531378","url":null,"abstract":"<p><strong>Introduction: </strong>Kidney biopsy is the cornerstone for the diagnosis of glomerular diseases and to guide treatment. Percutaneous ultrasound-guided kidney biopsy is currently the gold standard to obtain cortical specimens. However, in cases where ultrasound-guided kidney biopsy is not deemed safe (obese patients, deep kidneys, or kidneys with a complicated anatomy), CT-guided kidney biopsy could be a convenient alternative to obtain renal tissue samples. The aim of this study was to describe the diagnostic yield and complications of CT-guided kidney biopsies in patients with glomerular diseases that were previously discarded for ultrasound-guided kidney biopsy.</p><p><strong>Material and methods: </strong>We performed a retrospective, single-center, observational study including patients who underwent CT-guided native kidney biopsies in our center after being contraindicated for ultrasound-guided biopsy. Patients' records were reviewed retrieving baseline characteristics and pre-biopsy clinical, laboratory parameters and concomitant medication. The biopsy needle gauge, site of puncture, and number of needle passes were recorded. The diagnostic yield was evaluated by the number of glomeruli obtained, the rate of specimens that were adequate to reach diagnosis, and the number of biopsies that had to be repeated. Complications were defined as minor (hypotension, hematoma) and major (arteriovenous fistulae, major bleeding requiring embolization, or nephrectomy). The diagnostic yield and complications were compared to ultrasound-guided native kidney biopsies performed during the same period.</p><p><strong>Results: </strong>56 CT-guided native kidney biopsies were performed during the study period. The number of glomeruli obtained per patient was 11.5 ± 6.3, which was inferior to that obtained from ultrasound-guided biopsies (14.08 ± 8.47, p &lt; 0.05). However, the rate of specimens that were adequate to reach a diagnosis was similar (92.9% vs. 90.8%, p = 0.437). The number of needle passes was higher in CT-guided kidney biopsies (2.0 ± 0.7 vs. 1.7 ± 0.5, p &lt; 0.05), as well as the incidence of post-biopsy perirenal asymptomatic hematomas (66.1% vs. 24.5%, p &lt; 0.01). There were no significant differences in other post-biopsy minor complications (1.8% vs. 2.5%, p = 0.621). There were no major complications after CT-guided kidney biopsies.</p><p><strong>Conclusions: </strong>CT-guided percutaneous kidney biopsy is a valid alternative for the diagnosis of glomerular diseases in patients with special characteristics such as obesity or deep kidneys that contraindicate ultrasound-guided biopsy. In this population, CT-guided kidney biopsies are safe and provide a high diagnostic yield, reaching a diagnosis in &gt;90% of patients that had been previously discarded for ultrasound-guided biopsy.</p>","PeriodicalId":18998,"journal":{"name":"Nephron","volume":" ","pages":"16-21"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10125778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信